Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease
暂无分享,去创建一个
T. Joh | G. Halliday | L. Geffen | Y. W. Li | R. Cotton | W. Blessing | P. Howe | R G Cotton | P. Blumbergs | W. Blessing | G M Halliday | Y W Li | P C Blumbergs | T H Joh | P R Howe | W W Blessing | L B Geffen | Dphil | L. Geffen | R. G. H. Cotton | PhD G. M. Halhday | MS P. C Y. W. Li | Frcpa Blumbergs | DSc PhDJ R. G. H. Cotton | PhD P. R. C. Howe | Fracp W. W. Blessing | Dr Hdiday | DPhil
[1] J. Chalmers,et al. Simultaneous demonstration of phenylethanolamine N-methyltransferase immunofluorescent and catecholamine fluorescent nerve cell bodies in the rat medulla oblongata , 1980, Neuroscience.
[2] T. Joh,et al. Evidence for retrograde degeneration of epinephrine neurons in Alzheimer's disease , 1988, Annals of neurology.
[3] P. Yates,et al. PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE , 1983, Neuropathology and applied neurobiology.
[4] C. Milstein,et al. Detection of substance P in the central nervous system by a monoclonal antibody. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. Eadie. THE PATHOLOGY OF CERTAIN MEDULLARY NUCLEI IN PARKINSONISM. , 1963, Brain : a journal of neurology.
[6] P. Yates,et al. The topography of cell loss from locus caeruleus in Alzheimer's disease , 1986, Journal of the Neurological Sciences.
[7] D. German,et al. Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex , 1987, Neuroscience.
[8] Y. Agid,et al. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease , 1983, Brain Research.
[9] T. Hökfelt,et al. Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in the human medulla oblongata , 1983, Neuroscience Letters.
[10] T. Joh,et al. Distribution of monoamine‐synthesizing neurons in the human medulla oblongata , 1988, The Journal of comparative neurology.
[11] F. E. Bloom,et al. Loss of pigmented dopamine-β-hydroxylase positive cells from locus coeruleus in senile dementia of alzheimer's type , 1983, Neuroscience Letters.
[12] G. Blessed,et al. Cell loss in the locus coeruleus in senile dementia of Alzheimer type , 1981, Journal of the Neurological Sciences.
[13] Larry L. Butcher,et al. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain , 1986, Brain Research Bulletin.
[14] D. Price,et al. The neuropathology of aminergic nuclei in Alzheimer's disease , 1988, Progress in clinical and biological research.
[15] C. Duyckaerts,et al. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients , 1986, Brain Research.
[16] G. Paxinos,et al. The Rat Brain in Stereotaxic Coordinates , 1983 .
[17] B. Bogerts,et al. A morphometric study of the dopamine-containing cell groups in the mesencephalon of normals, Parkinson patients, and schizophrenics. , 1983, Biological psychiatry.
[18] J. Olszewski,et al. Cytoarchitecture of the Human Brain Stem , 1955 .
[19] W. Gibb,et al. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[20] D L Price,et al. Parkinson's disease , 1985, Neurology.
[21] D L Price,et al. Aminergic systems in Alzheimer's disease and Parkinson's disease , 1987, Annals of neurology.
[22] P. Yates,et al. Dopaminergic neurotransmitter systems in Alzheimer's disease and in Down's syndrome at middle age. , 1987, Journal of neurology, neurosurgery, and psychiatry.
[23] D. Price,et al. Reductions in acetylcholine and nicotine binding in several degenerative diseases. , 1988, Archives of neurology.
[24] T. Joh,et al. Distribution of substance P‐like immunoreactive neurons in the human medulla oblongata: Co‐localization with monoamine‐synthesizing neurons , 1988, Synapse.
[25] A M Graybiel,et al. Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Spencer,et al. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus , 1987, Brain Research.
[27] A. Hirano,et al. Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons , 1985, Annals of neurology.
[28] J. Pearson,et al. Human brainstem catecholamine neuronal anatomy as indicated by immunocytochemistry with antibodies to tyrosine hydroxylase , 1983, Neuroscience.
[29] D L Price,et al. The pedunculopontine nucleus in Parkinson's disease , 1989, Annals of neurology.
[30] G. M. Halliday,et al. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's disease , 1990, Brain Research.
[31] Wade K. Smith,et al. The human locus coeruleus: computer reconstruction of cellular distribution , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[32] Y. Agid,et al. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains , 1983, Brain Research.
[33] A. Graybiel,et al. Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease , 1988, Nature.
[34] M. Fiacco,et al. Topographical localization of substance P in the human post-mortem brainstem. An immunohistochemical study in the newborn and adult tissue , 1984, Neuroscience.
[35] H. Fibiger,et al. Substance P in the ascending cholinergic reticular system , 1983, Nature.
[36] K. Jellinger,et al. Overview of morphological changes in Parkinson's disease. , 1987, Advances in neurology.
[37] T. Joh,et al. The distribution of neuropeptide Y-like immunoreactive neurons in the human medulla oblongata , 1988, Neuroscience.
[38] J. Willoughby,et al. Distribution of tyrosine hydroxylase and neuropeptide Y–like immunoreactive neurons in rabbit medulla oblongata, with attention to colocalization studies, presumptive adrenaline‐synthesizing perikarya, and vagal preganglionic cells , 1986, The Journal of comparative neurology.
[39] W. Bondareff,et al. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia , 1982, Neurology.
[40] K. Jellinger,et al. The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. , 1988, Journal of neurology, neurosurgery, and psychiatry.
[41] A. Cuello,et al. Identification of serotonergic neurons in human brain by a monoclonal antibody binding to all three aromatic amino acid hydroxylases , 1987, Brain Research.
[42] K. Kitahama,et al. Adrenergic neurons in human brain demonstrated by immunohistochemistry with antibodies to phenylethanolamine-N-methyltransferase (PNMT): Discovery of a new group in the nucleus tractus solitarius , 1985, Neuroscience Letters.